hotspot -WSS

hotspot

author：fashion 2025-09-27 12:23:13 - browse：38666

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： CDC advisory panel says seniors 'may' get RSV vaccine

WSS

How to make AI work for medicine

Sana to lay off nearly a third of staff, de

AstraZeneca bets AAV gene therapy will still deliver the goods

Winners, losers from Medicare’s list of drugs subject to price talks

Psilocybin's anti

FDA panel gives mixed vote on blood pressure devices

knowledge

hotspot

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Sana to lay off nearly a third of staff, de

New air purifier tech could be key to improving indoor air quality

Stroke deaths set to near 10 million globally by 2050

In age of alternative facts, a scholarly course on calling out crap

Why more medical students aren't specializing in primary care

Activists slam private health insurers over coverage restrictions

Appeals court upholds limits to abortion pill

Medical records are filled with copy

Drug firms test therapies to halt Alzheimer’s before symptoms arise

explore

What AAP's gender

Colorectal cancer study finds potential in overlooked immune cell

In science, is the line between industry and academia shifting?

2024 GOP presidential candidates spar over abortion in debate

Diversity in medical illustrations gets boost from Chidiebere Ibe

Stroke deaths set to near 10 million globally by 2050

hotspot

entertainment

focus

explore